Back
Home
Search
HR+/HER2 neg
Protocols
UW22102
OPEN TO ACCRUAL
RaPhLRR - PII Ribociclib + Endocrine Tx for Recurrent, Resected HR+ HER2- Breast Cancer
NRGBR009
OPEN TO ACCRUAL
Trial Evaluating Addition of Adjuvant Chemo to Ovarian Function Suppression + Endocrine Therapy